EN
HI
Summary
As of 20 Oct, 2026, Parmax Pharma stock price is ₹136.4. During the trading session, the stock has moved between an intraday low of ₹136.40 and an intraday high of ₹136.40. Over the last 52 weeks, Parmax Pharma has traded between ₹22.60 and ₹139.10.
The stock has recorded a trading volume of 271 shares,. Its Average Traded Price (ATP) is ₹136.40, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹136.40.
Parmax Pharma has an upper circuit limit of ₹137.75 and a lower circuit limit of ₹135.05. The total value traded stands at ₹36964.40, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Parmax Pharma also offers a dividend yield of 0%.
Parmax Pharma Share Price Chart
Parmax Pharma Share Key Metrics
Volume
271.00
Market Cap
93.83 CR
LTQ@LTP
1@136.40
ATP
136.4
Var Margin
0 %
Circuit Range
135.05-137.75
Delivery %
100 %
Value
36964.40
ASM/GSM
No
Market Lot
1
Parmax Pharma Resistance and Support
Pivot 136.4
Resistance
First Resistance
136.4
Second Resistance
136.4
Third Resistance
136.4
Support
First Support
136.4
Second Support
136.4
Third Support
136.4
Parmax Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 19 2026 | 136.39 | 136.39 | -0.99% | 136.39 | 136.39 |
| Mon Oct 12 2026 | 139.1 | 137.75 | -0.97% | 139.1 | 137.75 |
| Mon Oct 05 2026 | 137.75 | 139.1 | 0.98% | 139.1 | 136.39 |
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-06-08 | Fund raising |
| 2026-06-02 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Parmax Pharma Management
| Name | Position |
|---|---|
| Umang A Gosalia | Managing Director |
| Nikhil Uchat | Non Executive Independent Director |
Parmax Pharma Similar Stocks
Venmax Drugs And Pharmaceuticals Ltd.
14.40
-0.03 (0.21%)
Beryl Drugs Ltd.
24.88
0.04 (0.16%)
Sharma East India Hospitals & Medical Research Ltd
81.51
0.00 (0.00%)
Norris Medicines Ltd.
16.00
0.00 (0.00%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Starsource Multitrade Ltd.
115.00
0.00 (0.00%)
Colinz Laboratories Ltd.
70.00
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
14.00
0.00 (0.00%)
Unjha Formulations Ltd.
31.50
0.33 (1.06%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 136.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 39.69 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 93.83 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 139.10 & 22.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PARMAX
